REZENOPY FDA approval date

The FDA approved REZENOPY on 19 Apr 2024.

FDA approval date
19 Apr 2024

Drug identity has not yet been verified against registry records

Also recorded as NALOXONE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-04-19DayREZENOPYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215487", "applicant_as_listed_by_fda": "SCIENTURE", "brand_names": ["REZENOPY"], "active_ingredients": ["NALOXONE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240419", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026